Fulgent Genetics Depreciation & Amortization 2011-2026 | FLGT

Annual Depreciation & Amortization Fulgent Genetics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
24.9 M	26.1 M	32.7 M	11 M	2.96 M	2.11 M	2.16 M	1.73 M	1.17 M	575 K	196 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
32.7 M	196 K	9.6 M

Quarterly Depreciation & Amortization Fulgent Genetics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.9 M	3.9 M	5.92 M	-	3.8 M	4 M	6.66 M	-	6.42 M	6.31 M	6.88 M	-	7.6 M	6.6 M	4.7 M	911 K	7.51 M	2.3 M	1.92 M	-	1.84 M	1.12 M	569 K	-	503 K	511 K	535 K	-	547 K	562 K	516 K	-	438 K	405 K	412 K	-	304 K	248 K	199 K	-	171 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
7.6 M	171 K	2.76 M

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Agilent Technologies A	321 M	$ 115.48	0.82 %	$ 35.1 B	USA
Burning Rock Biotech Limited BNR	47.8 M	$ 16.2	-0.61 %	$ 175 M	China
Biodesix BDSX	5.77 M	$ 15.07	2.1 %	$ 1.95 B	USA
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	1.11 M	$ 4.4	101.83 %	$ 5.85 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
Castle Biosciences CSTL	16 M	$ 24.84	-0.84 %	$ 690 M	USA
DarioHealth Corp. DRIO	307 K	$ 8.4	3.7 %	$ 33.5 M	Israel
BioNano Genomics BNGO	9.53 M	$ 1.2	0.84 %	$ 6.53 M	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Charles River Laboratories International CRL	403 M	$ 173.89	-0.58 %	$ 8.62 B	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
DexCom DXCM	252 M	$ 62.22	-0.24 %	$ 24.3 B	USA
Biomerica BMRA	87 K	$ 2.17	-0.91 %	$ 4.98 M	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
Celcuity CELC	167 K	$ 112.63	-0.27 %	$ 5.27 B	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Quest Diagnostics Incorporated DGX	570 M	$ 198.02	0.17 %	$ 22 B	USA
Guardant Health GH	39.7 M	$ 93.83	2.94 %	$ 11.8 B	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Lantheus Holdings LNTH	70.1 M	$ 76.1	0.53 %	$ 5.14 B	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
Medpace Holdings MEDP	27.2 M	$ 498.34	1.81 %	$ 14.4 B	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Interpace Biosciences IDXG	425 K	$ 1.96	5.82 %	$ 8.67 M	USA
Mettler-Toledo International MTD	51.1 M	$ 1 259.94	-1.11 %	$ 26 B	Schweiz
ICON Public Limited Company ICLR	488 M	$ 114.19	2.49 %	$ 9.42 B	Irlanda
IDEXX Laboratories IDXX	145 M	$ 569.55	0.87 %	$ 45.8 B	USA
Neogen Corporation NEOG	119 M	$ 9.41	0.21 %	$ 2.04 B	USA
Illumina ILMN	354 M	$ 127.38	0.59 %	$ 20.3 B	USA
IQVIA Holdings IQV	1.14 B	$ 173.26	0.5 %	$ 29.8 B	USA
Pacific Biosciences of California PACB	13 M	$ 1.34	-0.74 %	$ 402 M	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	681 M	$ 273.72	0.36 %	$ 22.8 B	USA
Myriad Genetics MYGN	53.7 M	$ 4.75	3.49 %	$ 440 M	USA
Sotera Health Company SHC	94.9 M	$ 14.96	0.61 %	$ 4.25 B	USA
NeoGenomics NEO	36.1 M	$ 8.0	3.23 %	$ 1.02 B	USA
National Research Corporation NRC	7.62 M	$ 17.16	-1.04 %	$ 384 M	USA